Janney Montgomery Scott Starts Intellia Therapeutics (NTLA) at Buy

September 28, 2016 4:52 PM EDT
Get Alerts NTLA Hot Sheet
Price: $13.78 +10.59%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade NTLA Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Janney Montgomery Scott initiated coverage on Intellia Therapeutics (NASDAQ: NTLA) with a Buy rating and a price target of $29.00.

For an analyst ratings summary and ratings history on Intellia Therapeutics click here. For more ratings news on Intellia Therapeutics click here.

Shares of Intellia Therapeutics closed at $16.91 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot New Coverage, New Coverage

Related Entities

Janney Montgomery Scott

Add Your Comment